AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback